.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020090

« Back to Dashboard
NDA 020090 describes DIFLUCAN, which is a drug marketed by Pfizer and is included in three NDAs. It is available from eight suppliers. Additional details are available on the DIFLUCAN profile page.

The generic ingredient in DIFLUCAN is fluconazole. There are twenty-three drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the fluconazole profile page.

Summary for NDA: 020090

Tradename:
DIFLUCAN
Applicant:
Pfizer
Ingredient:
fluconazole
Patents:0
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 020090

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIFLUCAN
fluconazole
FOR SUSPENSION;ORAL 020090 NDA Roerig 0049-3440 0049-3440-19 1 BOTTLE in 1 CARTON (0049-3440-19) > 35 mL in 1 BOTTLE
DIFLUCAN
fluconazole
FOR SUSPENSION;ORAL 020090 NDA Roerig 0049-3450 0049-3450-19 1 BOTTLE in 1 CARTON (0049-3450-19) > 35 mL in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION;ORALStrength50MG/5ML
Approval Date:Dec 23, 1993TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION;ORALStrength200MG/5ML
Approval Date:Dec 23, 1993TE:ABRLD:Yes

Expired Orange Book Patents for NDA: 020090

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer
DIFLUCAN
fluconazole
FOR SUSPENSION;ORAL020090-001Dec 23, 19934,404,216*PED► subscribe
Pfizer
DIFLUCAN
fluconazole
FOR SUSPENSION;ORAL020090-002Dec 23, 19934,416,682► subscribe
Pfizer
DIFLUCAN
fluconazole
FOR SUSPENSION;ORAL020090-002Dec 23, 19934,404,216*PED► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc